← FDA Drug Approvals (Drugs@FDA)

XHANCE

NDA · New Drug Application · Sponsor: PARATEK PHARMS · Approved 2017-09-18

Drug application

FDA Application #

NDA209022

Application type

New Drug Application

Brand name

XHANCE

Generic name

FLUTICASONE PROPIONATE

Active ingredients

FLUTICASONE PROPIONATE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

PARATEK PHARMS

Manufacturer

OptiNose US, Inc.

First approval

2017-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown